Myeloma Center Awarded Prestigious LLS Translational Research Grant

The Myeloma Center in collaboration with Weill Cornell's Monical Guzman, PhD have received a prestigious translational research grant from the Leukemia and Lymphoma Society (LLS) to study the genesis of secondary malignancies in Multiple Myeloma.

Multiple Myeloma is characterized by the uncontrolled proliferation of malignant plasma cells. The introduction of novel agents has resulted in improvement in survival. However, long term use of these agents may lead to the development of second primary malignancies (SPM).

The grant will allow the researchers to examine factors that contribute to the development of secondary malignancies and identify early changes that could be used as predictors of the risk for SPMs."

The Myeloma Center finishes move to new building

The Myeloma Center has successfully transitioned to the 428 E 72nd street practice in the Oxford building. In this practice, you will have consultations with your physician and undergo treatment in a comfortable and personal clinic setting. All myeloma-related procedures are done on site by the physicians as well for convenience.